Drug Interactions of Psychiatric and COVID-19 Medications.

Antidepressants Antipsychotics Anxiolytics COVID-19 Chloroquine Drug interaction

Journal

Basic and clinical neuroscience
ISSN: 2008-126X
Titre abrégé: Basic Clin Neurosci
Pays: Iran
ID NLM: 101575211

Informations de publication

Date de publication:
Historique:
received: 16 04 2020
revised: 25 04 2020
accepted: 26 04 2020
entrez: 29 8 2020
pubmed: 29 8 2020
medline: 29 8 2020
Statut: ppublish

Résumé

Coronavirus disease 2019 (COVID-19) has become a pandemic with 1771514 cases identified in the world and 70029 cases in Iran until April 12, 2020. The co-prescription of psychotropics with COVID-19 medication is not uncommon. Healthcare providers should be familiar with many Potential Drug-Drug Interactions (DDIs) between COVID-19 therapeutic agents and psychotropic drugs based on cytochrome P450 metabolism. This review comprehensively summarizes the current literature on DDIs between antiretroviral drugs and chloroquine/hydroxychloroquine, and psychotropics, including antidepressants, antipsychotics, mood stabilizers, and anxiolytics. Medical databases, including Google Scholar, PubMed, Web of Science, and Scopus were searched to identify studies in English with keywords related to psychiatric disorders, medications used in the treatment of psychiatric disorders and COVID-19 medications. There is a great potential for DDIs between psychiatric and COVID-19 medications ranging from interactions that are not clinically apparent (minor) to those that produce life-threatening adverse drug reactions, or loss of treatment efficacy. The majority of interactions are pharmacokinetic interactions via the cytochrome P450 enzyme system. DDIs are a major concern in the comorbidity of psychiatric disorders and COVID-19 infection resulting in the alteration of expected therapeutic outcomes. The risk of toxicity or lack of efficacy may occur due to a higher or lower plasma concentration of medications. However, psychiatric medication can be safely used in combination with COVID-19 pharmacotherapy with either a wise selection of medication with the least possibility of interaction or careful patient monitoring and management.

Identifiants

pubmed: 32855778
doi: 10.32598/bcn.11.covid19.2500.1
pii: BCN-11-185
pmc: PMC7368108
doi:

Types de publication

Journal Article Review

Langues

eng

Pagination

185-200

Informations de copyright

Copyright© 2020 Iranian Neuroscience Society.

Références

Malar J. 2016 May 17;15(1):280
pubmed: 27188854
Am J Psychiatry. 1958 Nov;115(5):459-64
pubmed: 13583250
Eur J Clin Pharmacol. 2008 May;64(5):531-8
pubmed: 18196226
Curr Drug Metab. 2010 Nov;11(9):815-29
pubmed: 21189133
JAMA. 2020 Apr 7;323(13):1239-1242
pubmed: 32091533
Pharmacol Res. 2016 Apr;106:72-86
pubmed: 26896788
J Acquir Immune Defic Syndr. 2004 Aug 15;36(5):1034-40
pubmed: 15247556
J Acquir Immune Defic Syndr. 2008 Dec 1;49(4):358-68
pubmed: 19186349
Mol Pharmacol. 1989 Jul;36(1):89-96
pubmed: 2787473
Br Med J (Clin Res Ed). 1986 May 17;292(6531):1319-21
pubmed: 3085830
J Clin Psychopharmacol. 1999 Aug;19(4):293-6
pubmed: 10440454
Antimicrob Agents Chemother. 2008 May;52(5):1663-9
pubmed: 18285471
Biochem Biophys Res Commun. 2013 Jun 14;435(4):708-13
pubmed: 23702482
Ann Intern Med. 2020 May 19;172(10):699-701
pubmed: 32176272
Clin Pharmacokinet. 2011 Jan;50(1):25-39
pubmed: 21142266
J Clin Psychiatry. 1997;58 Suppl 5:7-14
pubmed: 9184622
Int J Antimicrob Agents. 2014 Aug;44(2):173-7
pubmed: 24929949
J Clin Pharmacol. 2003 Apr;43(4):414-22
pubmed: 12723462
Eur J Clin Pharmacol. 2007 Dec;63(12):1147-51
pubmed: 17828532
Clin Pharmacokinet. 1996 Oct;31(4):257-74
pubmed: 8896943
Am J Psychiatry. 1999 Jun;156(6):969-70
pubmed: 10360146
Antimicrob Agents Chemother. 2004 Nov;48(11):4328-31
pubmed: 15504860
Curr Drug Metab. 2010 Jul;11(6):516-25
pubmed: 20540690
Ann Pharmacother. 2003 Feb;37(2):202-5
pubmed: 12549947
Drug Metab Dispos. 2003 Jul;31(7):815-32
pubmed: 12814957
N Engl J Med. 2020 Apr 30;382(18):1708-1720
pubmed: 32109013
Acta Neurol Scand. 2008 Aug;118(2):69-86
pubmed: 18384456
J Clin Psychopharmacol. 2002 Apr;22(2):169-73
pubmed: 11910262
J Clin Psychopharmacol. 2004 Aug;24(4):386-8
pubmed: 15232329
Pharmacotherapy. 2001 Feb;21(2):163-8
pubmed: 11213852
J Virol. 2004 Oct;78(19):10410-9
pubmed: 15367607
Int J Antimicrob Agents. 2020 Mar;55(3):105924
pubmed: 32081636
Ment Health Clin. 2016 Mar 08;6(1):21-27
pubmed: 29955443
Rev Med Interne. 2010 Feb;31(2):170-9
pubmed: 19740579
Clin Ther. 2014 Nov 1;36(11):1638-49
pubmed: 25236915
Neurotoxicology. 2004 Jan;25(1-2):215-21
pubmed: 14697896
Clin Ther. 2003 Apr;25(4):1200-10
pubmed: 12809966
Clin Pharmacokinet. 2016 Dec;55(12):1471-1494
pubmed: 27317413
Drug Metab Dispos. 2001 Aug;29(8):1102-9
pubmed: 11454728
Clin Pharmacol Ther. 2008 Jul;84(1):75-82
pubmed: 18183034
Ann Intern Med. 2002 Sep 3;137(5 Pt 2):381-433
pubmed: 12617573
Eur J Clin Pharmacol. 2012 Jan;68(1):29-37
pubmed: 21739267
Antimicrob Agents Chemother. 1998 Dec;42(12):3107-12
pubmed: 9835499
J Interv Card Electrophysiol. 2007 Apr;18(3):243-6
pubmed: 17546486
Clin Ther. 2008 Jul;30(7):1206-27
pubmed: 18691982
Br J Pharmacol. 2007 Jul;151(6):737-48
pubmed: 17471183
CNS Drugs. 2003;17(7):513-32
pubmed: 12751920
J Assoc Physicians India. 1995 Jan;43(1):17-8
pubmed: 9282631
Drug Metab Dispos. 2003 Jun;31(6):748-54
pubmed: 12756207
Ann Pharmacother. 2013 Jan;47(1):75-89
pubmed: 23341158
Ann Pharmacother. 2006 Jan;40(1):147-50
pubmed: 16368918
Rheumatology (Oxford). 2008 Mar;47(3):378-9
pubmed: 18222983
Clin Pharmacokinet. 1998 Oct;35(4):275-91
pubmed: 9812178
Clin Infect Dis. 2006 May 1;42(9):1305-10
pubmed: 16586391
PLoS One. 2013 Oct 30;8(10):e76799
pubmed: 24204676
Biochem Pharmacol. 2003 May 1;65(9):1441-9
pubmed: 12732356
J Acquir Immune Defic Syndr. 2006 May;42(1):52-60
pubmed: 16639344
Curr Pharm Des. 2015;21(23):3343-51
pubmed: 26088119
Int J Biol Sci. 2020 Mar 15;16(10):1732-1738
pubmed: 32226291
CNS Spectr. 2019 Jun;24(3):287-312
pubmed: 30295215
Proc (Bayl Univ Med Cent). 2000 Oct;13(4):421-3
pubmed: 16389357
Drug Metab Dispos. 2010 Mar;38(3):376-85
pubmed: 20007670
Am J Psychiatry. 2000 Apr;157(4 Suppl):1-45
pubmed: 10767867
Indian J Pharmacol. 2015 Sep-Oct;47(5):567-8
pubmed: 26600652
J Med Toxicol. 2007 Dec;3(4):178-81
pubmed: 18072173
AIDS. 2001 Jul 6;15(10):1281-5
pubmed: 11426073
Clin Pharmacol Ther. 2007 Jan;81(1):69-75
pubmed: 17186001
Clin Pharmacol Ther. 2009 Jan;85(1):64-70
pubmed: 18815591
Eur J Clin Pharmacol. 2003 Sep;59(5-6):401-6
pubmed: 12898080
J Clin Pharmacol. 2006 May;46(5):567-76
pubmed: 16638740
Trop Geogr Med. 1988 Jan;40(1):31-3
pubmed: 3381314
Am J Med Sci. 1995 Jun;309(6):315-6
pubmed: 7771501
Clin Neurosci Res. 2002 Dec;2(3-4):193-212
pubmed: 22707923
Asian J Psychiatr. 2020 Mar;49:101989
pubmed: 32143142
Drug Metab Dispos. 2000 Oct;28(10):1187-91
pubmed: 10997938
J Clin Pharmacol. 2013 Jun;53(6):654-61
pubmed: 23381882
Clin Pharmacokinet. 1997;32 Suppl 1:1-21
pubmed: 9068931
Pharmaceutics. 2017 Dec 21;10(1):
pubmed: 29267251
Ochsner J. 2013 Summer;13(2):214-23
pubmed: 23789008
J Clin Pharmacol. 2010 Oct;50(10):1180-7
pubmed: 20484617
J Am Acad Child Adolesc Psychiatry. 2002 Sep;41(9):1037-44
pubmed: 12218424
Clin Pharmacol Ther. 2006 Aug;80(2):159-68
pubmed: 16890577
Handb Exp Pharmacol. 2019;250:145-180
pubmed: 30838456
Drug Metab Dispos. 2011 Jun;39(6):1070-8
pubmed: 21406602
Pharmacotherapy. 2009 Oct;29(10):1175-81
pubmed: 19792991
J Affect Disord. 1998 Dec;51(3):237-54
pubmed: 10333980
J Acquir Immune Defic Syndr. 2000 Jun 1;24(2):129-36
pubmed: 10935688
Immunopharmacol Immunotoxicol. 2013 Jun;35(3):434-42
pubmed: 23635029
J Clin Rheumatol. 2011 Jan;17(1):46-7
pubmed: 21169846
Pharmacotherapy. 2009 Nov;29(11):1386-91
pubmed: 19857154
Br J Clin Pharmacol. 2007 Aug;64(2):192-7
pubmed: 17298480
Curr Drug Metab. 2008 Jun;9(5):410-8
pubmed: 18537577
Lancet. 1964 Nov 7;2(7367):995-7
pubmed: 14201672
Clin Pharmacokinet. 1995;29 Suppl 1:1-9
pubmed: 8846617
J Rheumatol. 1999 Jan;26(1):195-6
pubmed: 9918262
J Clin Psychopharmacol. 2005 Jun;25(3):226-9
pubmed: 15876900
Clin Pharmacol Ther. 2003 Mar;73(3):170-7
pubmed: 12621382
Clin Neuropharmacol. 2002 Sep-Oct;25(5):251-3
pubmed: 12410055
Drug Metab Dispos. 2001 Feb;29(2):100-2
pubmed: 11159797
Pacing Clin Electrophysiol. 2007 Dec;30(12):1579-82
pubmed: 18070319
Biol Psychiatry. 2000 Apr 1;47(7):655-61
pubmed: 10745059
Ther Drug Monit. 2011 Feb;33(1):21-4
pubmed: 21157400
Antimicrob Agents Chemother. 2007 Nov;51(11):4098-104
pubmed: 17846135
Ann Pharmacother. 2002 May;36(5):827-30
pubmed: 11978161
Int J Clin Pharm. 2011 Jun;33(3):484-92
pubmed: 21487738
J Psychiatr Pract. 2012 Sep;18(5):361-8
pubmed: 22995963
J Clin Psychopharmacol. 2002 Aug;22(4):366-70
pubmed: 12172335
Ann Pharmacother. 2002 Jul-Aug;36(7-8):1193-203
pubmed: 12086554
Ther Adv Psychopharmacol. 2017 Dec;7(12):251-264
pubmed: 29201344
Clin Pharmacol Ther. 2005 Dec;78(6):664-74
pubmed: 16338282
Pharmacoepidemiol Drug Saf. 2008 Apr;17(4):336-44
pubmed: 18302302
Br Med Bull. 2015 Jun;114(1):169-79
pubmed: 25957394
J Clin Med. 2020 Mar 31;9(4):
pubmed: 32244415
Lancet. 1966 Feb 19;1(7434):407-9
pubmed: 4159787

Auteurs

Niayesh Mohebbi (N)

Department of Clinical Pharmacy, School of Pharmacy, Tehran University of Medical Sciences, Tehran, Iran.
Research Center for Rational Use of Drugs; Tehran University of Medical Sciences, Tehran, Iran.

Ali Talebi (A)

Department of Clinical Pharmacy, School of Pharmacy, Tehran University of Medical Sciences, Tehran, Iran.

Marjan Moghadamnia (M)

Department of Clinical Pharmacy, School of Pharmacy, Tehran University of Medical Sciences, Tehran, Iran.

Zahra Nazari Taloki (Z)

Department of Clinical Pharmacy, School of Pharmacy, Tehran University of Medical Sciences, Tehran, Iran.

Alia Shakiba (A)

Department of Psychiatry, Roozbeh Hospital, Tehran University of Medical Sciences, Tehran, Iran.

Classifications MeSH